nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlodipine—CYP3A4—bone cancer	0.577	1	CbGaD
Amlodipine—CYP2B6—Cisplatin—bone cancer	0.0288	0.255	CbGbCtD
Amlodipine—CYP2B6—Doxorubicin—bone cancer	0.0193	0.171	CbGbCtD
Amlodipine—CYP2C9—Cisplatin—bone cancer	0.0152	0.135	CbGbCtD
Amlodipine—ABCB1—Cisplatin—bone cancer	0.0148	0.131	CbGbCtD
Amlodipine—CACNA1S—pes—bone cancer	0.0115	0.491	CbGeAlD
Amlodipine—ABCB1—Doxorubicin—bone cancer	0.0099	0.0877	CbGbCtD
Amlodipine—ABCB1—Methotrexate—bone cancer	0.00959	0.085	CbGbCtD
Amlodipine—CYP2D6—Doxorubicin—bone cancer	0.00933	0.0826	CbGbCtD
Amlodipine—CYP3A4—Doxorubicin—bone cancer	0.00593	0.0526	CbGbCtD
Amlodipine—CACNA1B—connective tissue—bone cancer	0.00139	0.0596	CbGeAlD
Amlodipine—SMPD1—connective tissue—bone cancer	0.00112	0.048	CbGeAlD
Amlodipine—Isradipine—CYP3A4—bone cancer	0.00106	0.144	CrCbGaD
Amlodipine—CACNA2D3—tendon—bone cancer	0.00102	0.0436	CbGeAlD
Amlodipine—CACNA2D3—bone marrow—bone cancer	0.000987	0.0423	CbGeAlD
Amlodipine—CACNA2D3—spinal cord—bone cancer	0.000983	0.0421	CbGeAlD
Amlodipine—Clevidipine—CYP3A4—bone cancer	0.000933	0.127	CrCbGaD
Amlodipine—CACNA1B—spinal cord—bone cancer	0.000922	0.0395	CbGeAlD
Amlodipine—Nisoldipine—CYP3A4—bone cancer	0.000895	0.121	CrCbGaD
Amlodipine—CACNA1S—tendon—bone cancer	0.000879	0.0376	CbGeAlD
Amlodipine—Nimodipine—CYP3A4—bone cancer	0.000864	0.117	CrCbGaD
Amlodipine—Nilvadipine—CYP3A4—bone cancer	0.000837	0.114	CrCbGaD
Amlodipine—Nitrendipine—CYP3A4—bone cancer	0.000837	0.114	CrCbGaD
Amlodipine—SMPD1—tendon—bone cancer	0.000769	0.033	CbGeAlD
Amlodipine—SMPD1—spinal cord—bone cancer	0.000742	0.0318	CbGeAlD
Amlodipine—Felodipine—CYP3A4—bone cancer	0.000666	0.0904	CrCbGaD
Amlodipine—Nifedipine—CYP3A4—bone cancer	0.000644	0.0874	CrCbGaD
Amlodipine—Nicardipine—CYP3A4—bone cancer	0.000634	0.0861	CrCbGaD
Amlodipine—CACNA1C—connective tissue—bone cancer	0.00062	0.0266	CbGeAlD
Amlodipine—CACNB2—tendon—bone cancer	0.000528	0.0226	CbGeAlD
Amlodipine—CACNA2D1—tendon—bone cancer	0.000496	0.0212	CbGeAlD
Amlodipine—CACNA2D1—bone marrow—bone cancer	0.00048	0.0206	CbGeAlD
Amlodipine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000437	0.00274	CcSEcCtD
Amlodipine—Gastritis—Doxorubicin—bone cancer	0.000433	0.00271	CcSEcCtD
Amlodipine—Pain—Cisplatin—bone cancer	0.000433	0.00271	CcSEcCtD
Amlodipine—Muscular weakness—Doxorubicin—bone cancer	0.000432	0.00271	CcSEcCtD
Amlodipine—Dysuria—Epirubicin—bone cancer	0.000428	0.00268	CcSEcCtD
Amlodipine—Conjunctivitis—Methotrexate—bone cancer	0.000423	0.00265	CcSEcCtD
Amlodipine—Dysphagia—Doxorubicin—bone cancer	0.000423	0.00265	CcSEcCtD
Amlodipine—Pollakiuria—Epirubicin—bone cancer	0.000422	0.00265	CcSEcCtD
Amlodipine—Feeling abnormal—Cisplatin—bone cancer	0.000417	0.00261	CcSEcCtD
Amlodipine—Weight increased—Epirubicin—bone cancer	0.000416	0.00261	CcSEcCtD
Amlodipine—Pancreatitis—Doxorubicin—bone cancer	0.000415	0.0026	CcSEcCtD
Amlodipine—Weight decreased—Epirubicin—bone cancer	0.000414	0.00259	CcSEcCtD
Amlodipine—Hyperglycaemia—Epirubicin—bone cancer	0.000413	0.00258	CcSEcCtD
Amlodipine—Epistaxis—Methotrexate—bone cancer	0.000411	0.00257	CcSEcCtD
Amlodipine—Neuropathy peripheral—Epirubicin—bone cancer	0.0004	0.0025	CcSEcCtD
Amlodipine—Jaundice—Epirubicin—bone cancer	0.000397	0.00249	CcSEcCtD
Amlodipine—Conjunctivitis—Epirubicin—bone cancer	0.000396	0.00248	CcSEcCtD
Amlodipine—Dysuria—Doxorubicin—bone cancer	0.000396	0.00248	CcSEcCtD
Amlodipine—Haemoglobin—Methotrexate—bone cancer	0.000393	0.00246	CcSEcCtD
Amlodipine—Haemorrhage—Methotrexate—bone cancer	0.000391	0.00245	CcSEcCtD
Amlodipine—Hepatitis—Methotrexate—bone cancer	0.000391	0.00245	CcSEcCtD
Amlodipine—Pollakiuria—Doxorubicin—bone cancer	0.000391	0.00245	CcSEcCtD
Amlodipine—Urinary tract disorder—Methotrexate—bone cancer	0.000386	0.00242	CcSEcCtD
Amlodipine—Weight increased—Doxorubicin—bone cancer	0.000385	0.00241	CcSEcCtD
Amlodipine—Epistaxis—Epirubicin—bone cancer	0.000385	0.00241	CcSEcCtD
Amlodipine—Urethral disorder—Methotrexate—bone cancer	0.000383	0.0024	CcSEcCtD
Amlodipine—Weight decreased—Doxorubicin—bone cancer	0.000383	0.0024	CcSEcCtD
Amlodipine—Hyperglycaemia—Doxorubicin—bone cancer	0.000382	0.00239	CcSEcCtD
Amlodipine—Visual impairment—Methotrexate—bone cancer	0.000377	0.00236	CcSEcCtD
Amlodipine—Hypersensitivity—Cisplatin—bone cancer	0.000373	0.00234	CcSEcCtD
Amlodipine—Bradycardia—Epirubicin—bone cancer	0.000373	0.00233	CcSEcCtD
Amlodipine—Erythema multiforme—Methotrexate—bone cancer	0.00037	0.00232	CcSEcCtD
Amlodipine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00037	0.00232	CcSEcCtD
Amlodipine—Haemoglobin—Epirubicin—bone cancer	0.000368	0.0023	CcSEcCtD
Amlodipine—Jaundice—Doxorubicin—bone cancer	0.000368	0.0023	CcSEcCtD
Amlodipine—Rhinitis—Epirubicin—bone cancer	0.000367	0.0023	CcSEcCtD
Amlodipine—Conjunctivitis—Doxorubicin—bone cancer	0.000367	0.0023	CcSEcCtD
Amlodipine—Haemorrhage—Epirubicin—bone cancer	0.000366	0.00229	CcSEcCtD
Amlodipine—Hepatitis—Epirubicin—bone cancer	0.000366	0.00229	CcSEcCtD
Amlodipine—Eye disorder—Methotrexate—bone cancer	0.000366	0.00229	CcSEcCtD
Amlodipine—Tinnitus—Methotrexate—bone cancer	0.000365	0.00228	CcSEcCtD
Amlodipine—CA1—bone marrow—bone cancer	0.000364	0.0156	CbGeAlD
Amlodipine—Hypoaesthesia—Epirubicin—bone cancer	0.000364	0.00228	CcSEcCtD
Amlodipine—Asthenia—Cisplatin—bone cancer	0.000363	0.00228	CcSEcCtD
Amlodipine—Cardiac disorder—Methotrexate—bone cancer	0.000363	0.00227	CcSEcCtD
Amlodipine—CA1—spinal cord—bone cancer	0.000363	0.0155	CbGeAlD
Amlodipine—Urinary tract disorder—Epirubicin—bone cancer	0.000361	0.00226	CcSEcCtD
Amlodipine—Oedema peripheral—Epirubicin—bone cancer	0.000361	0.00226	CcSEcCtD
Amlodipine—Connective tissue disorder—Epirubicin—bone cancer	0.00036	0.00225	CcSEcCtD
Amlodipine—Urethral disorder—Epirubicin—bone cancer	0.000359	0.00225	CcSEcCtD
Amlodipine—Epistaxis—Doxorubicin—bone cancer	0.000356	0.00223	CcSEcCtD
Amlodipine—Angiopathy—Methotrexate—bone cancer	0.000355	0.00222	CcSEcCtD
Amlodipine—Immune system disorder—Methotrexate—bone cancer	0.000353	0.00221	CcSEcCtD
Amlodipine—Visual impairment—Epirubicin—bone cancer	0.000353	0.00221	CcSEcCtD
Amlodipine—Mediastinal disorder—Methotrexate—bone cancer	0.000352	0.00221	CcSEcCtD
Amlodipine—Chills—Methotrexate—bone cancer	0.000351	0.0022	CcSEcCtD
Amlodipine—Diarrhoea—Cisplatin—bone cancer	0.000346	0.00217	CcSEcCtD
Amlodipine—Erythema multiforme—Epirubicin—bone cancer	0.000346	0.00217	CcSEcCtD
Amlodipine—Alopecia—Methotrexate—bone cancer	0.000346	0.00217	CcSEcCtD
Amlodipine—Bradycardia—Doxorubicin—bone cancer	0.000345	0.00216	CcSEcCtD
Amlodipine—Mental disorder—Methotrexate—bone cancer	0.000343	0.00215	CcSEcCtD
Amlodipine—Eye disorder—Epirubicin—bone cancer	0.000342	0.00214	CcSEcCtD
Amlodipine—Tinnitus—Epirubicin—bone cancer	0.000341	0.00214	CcSEcCtD
Amlodipine—Malnutrition—Methotrexate—bone cancer	0.00034	0.00213	CcSEcCtD
Amlodipine—Haemoglobin—Doxorubicin—bone cancer	0.00034	0.00213	CcSEcCtD
Amlodipine—Cardiac disorder—Epirubicin—bone cancer	0.00034	0.00213	CcSEcCtD
Amlodipine—Flushing—Epirubicin—bone cancer	0.00034	0.00213	CcSEcCtD
Amlodipine—Rhinitis—Doxorubicin—bone cancer	0.00034	0.00213	CcSEcCtD
Amlodipine—Haemorrhage—Doxorubicin—bone cancer	0.000339	0.00212	CcSEcCtD
Amlodipine—Hepatitis—Doxorubicin—bone cancer	0.000339	0.00212	CcSEcCtD
Amlodipine—Hypoaesthesia—Doxorubicin—bone cancer	0.000337	0.00211	CcSEcCtD
Amlodipine—Urinary tract disorder—Doxorubicin—bone cancer	0.000334	0.0021	CcSEcCtD
Amlodipine—Oedema peripheral—Doxorubicin—bone cancer	0.000334	0.00209	CcSEcCtD
Amlodipine—Dysgeusia—Methotrexate—bone cancer	0.000333	0.00209	CcSEcCtD
Amlodipine—Connective tissue disorder—Doxorubicin—bone cancer	0.000333	0.00209	CcSEcCtD
Amlodipine—Angiopathy—Epirubicin—bone cancer	0.000332	0.00208	CcSEcCtD
Amlodipine—Urethral disorder—Doxorubicin—bone cancer	0.000332	0.00208	CcSEcCtD
Amlodipine—Immune system disorder—Epirubicin—bone cancer	0.000331	0.00207	CcSEcCtD
Amlodipine—Mediastinal disorder—Epirubicin—bone cancer	0.00033	0.00207	CcSEcCtD
Amlodipine—Back pain—Methotrexate—bone cancer	0.000329	0.00206	CcSEcCtD
Amlodipine—Chills—Epirubicin—bone cancer	0.000328	0.00206	CcSEcCtD
Amlodipine—Arrhythmia—Epirubicin—bone cancer	0.000327	0.00205	CcSEcCtD
Amlodipine—Visual impairment—Doxorubicin—bone cancer	0.000326	0.00204	CcSEcCtD
Amlodipine—Alopecia—Epirubicin—bone cancer	0.000323	0.00203	CcSEcCtD
Amlodipine—Vomiting—Cisplatin—bone cancer	0.000322	0.00202	CcSEcCtD
Amlodipine—Mental disorder—Epirubicin—bone cancer	0.000321	0.00201	CcSEcCtD
Amlodipine—Erythema multiforme—Doxorubicin—bone cancer	0.00032	0.00201	CcSEcCtD
Amlodipine—Rash—Cisplatin—bone cancer	0.000319	0.002	CcSEcCtD
Amlodipine—Dermatitis—Cisplatin—bone cancer	0.000319	0.002	CcSEcCtD
Amlodipine—Malnutrition—Epirubicin—bone cancer	0.000319	0.002	CcSEcCtD
Amlodipine—Eye disorder—Doxorubicin—bone cancer	0.000316	0.00198	CcSEcCtD
Amlodipine—Ill-defined disorder—Methotrexate—bone cancer	0.000316	0.00198	CcSEcCtD
Amlodipine—Tinnitus—Doxorubicin—bone cancer	0.000316	0.00198	CcSEcCtD
Amlodipine—Cardiac disorder—Doxorubicin—bone cancer	0.000314	0.00197	CcSEcCtD
Amlodipine—Flushing—Doxorubicin—bone cancer	0.000314	0.00197	CcSEcCtD
Amlodipine—Flatulence—Epirubicin—bone cancer	0.000314	0.00197	CcSEcCtD
Amlodipine—Tension—Epirubicin—bone cancer	0.000313	0.00196	CcSEcCtD
Amlodipine—Dysgeusia—Epirubicin—bone cancer	0.000312	0.00195	CcSEcCtD
Amlodipine—Nervousness—Epirubicin—bone cancer	0.000309	0.00194	CcSEcCtD
Amlodipine—Back pain—Epirubicin—bone cancer	0.000308	0.00193	CcSEcCtD
Amlodipine—Angiopathy—Doxorubicin—bone cancer	0.000307	0.00193	CcSEcCtD
Amlodipine—Malaise—Methotrexate—bone cancer	0.000307	0.00192	CcSEcCtD
Amlodipine—Muscle spasms—Epirubicin—bone cancer	0.000306	0.00192	CcSEcCtD
Amlodipine—Immune system disorder—Doxorubicin—bone cancer	0.000306	0.00192	CcSEcCtD
Amlodipine—Vertigo—Methotrexate—bone cancer	0.000306	0.00192	CcSEcCtD
Amlodipine—Mediastinal disorder—Doxorubicin—bone cancer	0.000305	0.00191	CcSEcCtD
Amlodipine—Leukopenia—Methotrexate—bone cancer	0.000305	0.00191	CcSEcCtD
Amlodipine—Chills—Doxorubicin—bone cancer	0.000304	0.0019	CcSEcCtD
Amlodipine—Arrhythmia—Doxorubicin—bone cancer	0.000303	0.0019	CcSEcCtD
Amlodipine—Nausea—Cisplatin—bone cancer	0.000301	0.00188	CcSEcCtD
Amlodipine—Alopecia—Doxorubicin—bone cancer	0.000299	0.00188	CcSEcCtD
Amlodipine—Cough—Methotrexate—bone cancer	0.000297	0.00186	CcSEcCtD
Amlodipine—Mental disorder—Doxorubicin—bone cancer	0.000297	0.00186	CcSEcCtD
Amlodipine—Ill-defined disorder—Epirubicin—bone cancer	0.000296	0.00185	CcSEcCtD
Amlodipine—Malnutrition—Doxorubicin—bone cancer	0.000295	0.00185	CcSEcCtD
Amlodipine—Agitation—Epirubicin—bone cancer	0.000293	0.00183	CcSEcCtD
Amlodipine—Flatulence—Doxorubicin—bone cancer	0.000291	0.00182	CcSEcCtD
Amlodipine—Chest pain—Methotrexate—bone cancer	0.00029	0.00182	CcSEcCtD
Amlodipine—Myalgia—Methotrexate—bone cancer	0.00029	0.00182	CcSEcCtD
Amlodipine—Arthralgia—Methotrexate—bone cancer	0.00029	0.00182	CcSEcCtD
Amlodipine—Tension—Doxorubicin—bone cancer	0.000289	0.00181	CcSEcCtD
Amlodipine—Dysgeusia—Doxorubicin—bone cancer	0.000289	0.00181	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000288	0.0018	CcSEcCtD
Amlodipine—Malaise—Epirubicin—bone cancer	0.000287	0.0018	CcSEcCtD
Amlodipine—Discomfort—Methotrexate—bone cancer	0.000286	0.00179	CcSEcCtD
Amlodipine—Nervousness—Doxorubicin—bone cancer	0.000286	0.00179	CcSEcCtD
Amlodipine—Vertigo—Epirubicin—bone cancer	0.000286	0.00179	CcSEcCtD
Amlodipine—Syncope—Epirubicin—bone cancer	0.000286	0.00179	CcSEcCtD
Amlodipine—Leukopenia—Epirubicin—bone cancer	0.000285	0.00179	CcSEcCtD
Amlodipine—Back pain—Doxorubicin—bone cancer	0.000285	0.00179	CcSEcCtD
Amlodipine—Muscle spasms—Doxorubicin—bone cancer	0.000283	0.00178	CcSEcCtD
Amlodipine—Palpitations—Epirubicin—bone cancer	0.000282	0.00176	CcSEcCtD
Amlodipine—Loss of consciousness—Epirubicin—bone cancer	0.00028	0.00175	CcSEcCtD
Amlodipine—Cough—Epirubicin—bone cancer	0.000278	0.00174	CcSEcCtD
Amlodipine—Ill-defined disorder—Doxorubicin—bone cancer	0.000274	0.00171	CcSEcCtD
Amlodipine—Nervous system disorder—Methotrexate—bone cancer	0.000273	0.00171	CcSEcCtD
Amlodipine—Thrombocytopenia—Methotrexate—bone cancer	0.000272	0.0017	CcSEcCtD
Amlodipine—Myalgia—Epirubicin—bone cancer	0.000271	0.0017	CcSEcCtD
Amlodipine—Chest pain—Epirubicin—bone cancer	0.000271	0.0017	CcSEcCtD
Amlodipine—Arthralgia—Epirubicin—bone cancer	0.000271	0.0017	CcSEcCtD
Amlodipine—Agitation—Doxorubicin—bone cancer	0.000271	0.0017	CcSEcCtD
Amlodipine—Anxiety—Epirubicin—bone cancer	0.00027	0.00169	CcSEcCtD
Amlodipine—Skin disorder—Methotrexate—bone cancer	0.00027	0.00169	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000269	0.00169	CcSEcCtD
Amlodipine—Hyperhidrosis—Methotrexate—bone cancer	0.000269	0.00168	CcSEcCtD
Amlodipine—Discomfort—Epirubicin—bone cancer	0.000268	0.00168	CcSEcCtD
Amlodipine—Malaise—Doxorubicin—bone cancer	0.000266	0.00167	CcSEcCtD
Amlodipine—Dry mouth—Epirubicin—bone cancer	0.000265	0.00166	CcSEcCtD
Amlodipine—Vertigo—Doxorubicin—bone cancer	0.000265	0.00166	CcSEcCtD
Amlodipine—Anorexia—Methotrexate—bone cancer	0.000265	0.00166	CcSEcCtD
Amlodipine—Syncope—Doxorubicin—bone cancer	0.000264	0.00166	CcSEcCtD
Amlodipine—Leukopenia—Doxorubicin—bone cancer	0.000264	0.00165	CcSEcCtD
Amlodipine—Palpitations—Doxorubicin—bone cancer	0.000261	0.00163	CcSEcCtD
Amlodipine—Oedema—Epirubicin—bone cancer	0.00026	0.00163	CcSEcCtD
Amlodipine—Loss of consciousness—Doxorubicin—bone cancer	0.000259	0.00162	CcSEcCtD
Amlodipine—Cough—Doxorubicin—bone cancer	0.000257	0.00161	CcSEcCtD
Amlodipine—Shock—Epirubicin—bone cancer	0.000256	0.0016	CcSEcCtD
Amlodipine—Nervous system disorder—Epirubicin—bone cancer	0.000255	0.0016	CcSEcCtD
Amlodipine—Thrombocytopenia—Epirubicin—bone cancer	0.000255	0.0016	CcSEcCtD
Amlodipine—Tachycardia—Epirubicin—bone cancer	0.000254	0.00159	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000253	0.00159	CcSEcCtD
Amlodipine—Skin disorder—Epirubicin—bone cancer	0.000253	0.00158	CcSEcCtD
Amlodipine—Hyperhidrosis—Epirubicin—bone cancer	0.000251	0.00158	CcSEcCtD
Amlodipine—Insomnia—Methotrexate—bone cancer	0.000251	0.00157	CcSEcCtD
Amlodipine—Chest pain—Doxorubicin—bone cancer	0.000251	0.00157	CcSEcCtD
Amlodipine—Myalgia—Doxorubicin—bone cancer	0.000251	0.00157	CcSEcCtD
Amlodipine—Arthralgia—Doxorubicin—bone cancer	0.000251	0.00157	CcSEcCtD
Amlodipine—Anxiety—Doxorubicin—bone cancer	0.00025	0.00157	CcSEcCtD
Amlodipine—Paraesthesia—Methotrexate—bone cancer	0.00025	0.00156	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000249	0.00156	CcSEcCtD
Amlodipine—Discomfort—Doxorubicin—bone cancer	0.000248	0.00155	CcSEcCtD
Amlodipine—Anorexia—Epirubicin—bone cancer	0.000248	0.00155	CcSEcCtD
Amlodipine—Dyspnoea—Methotrexate—bone cancer	0.000248	0.00155	CcSEcCtD
Amlodipine—Somnolence—Methotrexate—bone cancer	0.000247	0.00155	CcSEcCtD
Amlodipine—Dry mouth—Doxorubicin—bone cancer	0.000245	0.00154	CcSEcCtD
Amlodipine—Dyspepsia—Methotrexate—bone cancer	0.000245	0.00153	CcSEcCtD
Amlodipine—Decreased appetite—Methotrexate—bone cancer	0.000242	0.00151	CcSEcCtD
Amlodipine—Oedema—Doxorubicin—bone cancer	0.000241	0.00151	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00024	0.0015	CcSEcCtD
Amlodipine—Fatigue—Methotrexate—bone cancer	0.00024	0.0015	CcSEcCtD
Amlodipine—Pain—Methotrexate—bone cancer	0.000238	0.00149	CcSEcCtD
Amlodipine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000238	0.00198	CbGpPWpGaD
Amlodipine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000237	0.00148	CcSEcCtD
Amlodipine—Shock—Doxorubicin—bone cancer	0.000237	0.00148	CcSEcCtD
Amlodipine—Nervous system disorder—Doxorubicin—bone cancer	0.000236	0.00148	CcSEcCtD
Amlodipine—Thrombocytopenia—Doxorubicin—bone cancer	0.000236	0.00148	CcSEcCtD
Amlodipine—Insomnia—Epirubicin—bone cancer	0.000235	0.00147	CcSEcCtD
Amlodipine—Tachycardia—Doxorubicin—bone cancer	0.000235	0.00147	CcSEcCtD
Amlodipine—Skin disorder—Doxorubicin—bone cancer	0.000234	0.00146	CcSEcCtD
Amlodipine—Paraesthesia—Epirubicin—bone cancer	0.000234	0.00146	CcSEcCtD
Amlodipine—Hyperhidrosis—Doxorubicin—bone cancer	0.000233	0.00146	CcSEcCtD
Amlodipine—Dyspnoea—Epirubicin—bone cancer	0.000232	0.00145	CcSEcCtD
Amlodipine—Somnolence—Epirubicin—bone cancer	0.000231	0.00145	CcSEcCtD
Amlodipine—CA1—Metabolism—NT5C3A—bone cancer	0.000229	0.00191	CbGpPWpGaD
Amlodipine—Anorexia—Doxorubicin—bone cancer	0.000229	0.00144	CcSEcCtD
Amlodipine—Feeling abnormal—Methotrexate—bone cancer	0.000229	0.00143	CcSEcCtD
Amlodipine—Dyspepsia—Epirubicin—bone cancer	0.000229	0.00143	CcSEcCtD
Amlodipine—CACNA1S—Alzheimers Disease—TP53—bone cancer	0.000229	0.00191	CbGpPWpGaD
Amlodipine—Gastrointestinal pain—Methotrexate—bone cancer	0.000227	0.00142	CcSEcCtD
Amlodipine—CACNA1D—Metabolism—NDUFA12—bone cancer	0.000227	0.00189	CbGpPWpGaD
Amlodipine—Decreased appetite—Epirubicin—bone cancer	0.000226	0.00142	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000225	0.00141	CcSEcCtD
Amlodipine—Fatigue—Epirubicin—bone cancer	0.000224	0.0014	CcSEcCtD
Amlodipine—Pain—Epirubicin—bone cancer	0.000222	0.00139	CcSEcCtD
Amlodipine—Constipation—Epirubicin—bone cancer	0.000222	0.00139	CcSEcCtD
Amlodipine—Urticaria—Methotrexate—bone cancer	0.000221	0.00138	CcSEcCtD
Amlodipine—Abdominal pain—Methotrexate—bone cancer	0.00022	0.00138	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000219	0.00137	CcSEcCtD
Amlodipine—Insomnia—Doxorubicin—bone cancer	0.000218	0.00136	CcSEcCtD
Amlodipine—Paraesthesia—Doxorubicin—bone cancer	0.000216	0.00135	CcSEcCtD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000215	0.00179	CbGpPWpGaD
Amlodipine—Dyspnoea—Doxorubicin—bone cancer	0.000215	0.00134	CcSEcCtD
Amlodipine—Feeling abnormal—Epirubicin—bone cancer	0.000214	0.00134	CcSEcCtD
Amlodipine—Somnolence—Doxorubicin—bone cancer	0.000214	0.00134	CcSEcCtD
Amlodipine—Gastrointestinal pain—Epirubicin—bone cancer	0.000213	0.00133	CcSEcCtD
Amlodipine—Dyspepsia—Doxorubicin—bone cancer	0.000212	0.00133	CcSEcCtD
Amlodipine—Decreased appetite—Doxorubicin—bone cancer	0.000209	0.00131	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000208	0.0013	CcSEcCtD
Amlodipine—Fatigue—Doxorubicin—bone cancer	0.000207	0.0013	CcSEcCtD
Amlodipine—Urticaria—Epirubicin—bone cancer	0.000207	0.00129	CcSEcCtD
Amlodipine—Pain—Doxorubicin—bone cancer	0.000206	0.00129	CcSEcCtD
Amlodipine—Constipation—Doxorubicin—bone cancer	0.000206	0.00129	CcSEcCtD
Amlodipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000206	0.00171	CbGpPWpGaD
Amlodipine—Abdominal pain—Epirubicin—bone cancer	0.000206	0.00129	CcSEcCtD
Amlodipine—Hypersensitivity—Methotrexate—bone cancer	0.000205	0.00128	CcSEcCtD
Amlodipine—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000203	0.0017	CbGpPWpGaD
Amlodipine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000203	0.00169	CbGpPWpGaD
Amlodipine—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000201	0.00167	CbGpPWpGaD
Amlodipine—Asthenia—Methotrexate—bone cancer	0.000199	0.00125	CcSEcCtD
Amlodipine—CACNA1C—Metabolism—NDUFA12—bone cancer	0.000199	0.00166	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—NT5C3A—bone cancer	0.000198	0.00165	CbGpPWpGaD
Amlodipine—Feeling abnormal—Doxorubicin—bone cancer	0.000198	0.00124	CcSEcCtD
Amlodipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000197	0.00164	CbGpPWpGaD
Amlodipine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000197	0.00123	CcSEcCtD
Amlodipine—Pruritus—Methotrexate—bone cancer	0.000197	0.00123	CcSEcCtD
Amlodipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000195	0.00163	CbGpPWpGaD
Amlodipine—CACNB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000194	0.00162	CbGpPWpGaD
Amlodipine—Hypersensitivity—Epirubicin—bone cancer	0.000192	0.0012	CcSEcCtD
Amlodipine—Urticaria—Doxorubicin—bone cancer	0.000191	0.0012	CcSEcCtD
Amlodipine—Abdominal pain—Doxorubicin—bone cancer	0.00019	0.00119	CcSEcCtD
Amlodipine—Diarrhoea—Methotrexate—bone cancer	0.00019	0.00119	CcSEcCtD
Amlodipine—CACNA1D—Metabolism—NT5C3A—bone cancer	0.000188	0.00156	CbGpPWpGaD
Amlodipine—Asthenia—Epirubicin—bone cancer	0.000187	0.00117	CcSEcCtD
Amlodipine—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000186	0.00155	CbGpPWpGaD
Amlodipine—CACNA1D—Alzheimers Disease—TP53—bone cancer	0.000186	0.00155	CbGpPWpGaD
Amlodipine—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000184	0.00154	CbGpPWpGaD
Amlodipine—Pruritus—Epirubicin—bone cancer	0.000184	0.00115	CcSEcCtD
Amlodipine—Dizziness—Methotrexate—bone cancer	0.000184	0.00115	CcSEcCtD
Amlodipine—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.000183	0.00153	CbGpPWpGaD
Amlodipine—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000182	0.00152	CbGpPWpGaD
Amlodipine—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000182	0.00152	CbGpPWpGaD
Amlodipine—Diarrhoea—Epirubicin—bone cancer	0.000178	0.00111	CcSEcCtD
Amlodipine—Hypersensitivity—Doxorubicin—bone cancer	0.000177	0.00111	CcSEcCtD
Amlodipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000177	0.00147	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000177	0.00147	CbGpPWpGaD
Amlodipine—Vomiting—Methotrexate—bone cancer	0.000177	0.00111	CcSEcCtD
Amlodipine—Rash—Methotrexate—bone cancer	0.000175	0.0011	CcSEcCtD
Amlodipine—Dermatitis—Methotrexate—bone cancer	0.000175	0.0011	CcSEcCtD
Amlodipine—Headache—Methotrexate—bone cancer	0.000174	0.00109	CcSEcCtD
Amlodipine—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000174	0.00145	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—MET—bone cancer	0.000174	0.00145	CbGpPWpGaD
Amlodipine—Asthenia—Doxorubicin—bone cancer	0.000173	0.00108	CcSEcCtD
Amlodipine—Dizziness—Epirubicin—bone cancer	0.000172	0.00108	CcSEcCtD
Amlodipine—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000172	0.00143	CbGpPWpGaD
Amlodipine—Pruritus—Doxorubicin—bone cancer	0.00017	0.00107	CcSEcCtD
Amlodipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000167	0.00139	CbGpPWpGaD
Amlodipine—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000165	0.00138	CbGpPWpGaD
Amlodipine—Vomiting—Epirubicin—bone cancer	0.000165	0.00104	CcSEcCtD
Amlodipine—Nausea—Methotrexate—bone cancer	0.000165	0.00103	CcSEcCtD
Amlodipine—CACNA1C—Metabolism—NT5C3A—bone cancer	0.000165	0.00137	CbGpPWpGaD
Amlodipine—Diarrhoea—Doxorubicin—bone cancer	0.000165	0.00103	CcSEcCtD
Amlodipine—Rash—Epirubicin—bone cancer	0.000164	0.00103	CcSEcCtD
Amlodipine—Dermatitis—Epirubicin—bone cancer	0.000164	0.00103	CcSEcCtD
Amlodipine—CACNA1C—Alzheimers Disease—TP53—bone cancer	0.000163	0.00136	CbGpPWpGaD
Amlodipine—Headache—Epirubicin—bone cancer	0.000163	0.00102	CcSEcCtD
Amlodipine—SMPD1—Metabolism—ENO2—bone cancer	0.000163	0.00136	CbGpPWpGaD
Amlodipine—CACNB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000163	0.00136	CbGpPWpGaD
Amlodipine—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.00016	0.00133	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000159	0.00133	CbGpPWpGaD
Amlodipine—Dizziness—Doxorubicin—bone cancer	0.000159	0.000997	CcSEcCtD
Amlodipine—Nausea—Epirubicin—bone cancer	0.000154	0.000968	CcSEcCtD
Amlodipine—Vomiting—Doxorubicin—bone cancer	0.000153	0.000958	CcSEcCtD
Amlodipine—Rash—Doxorubicin—bone cancer	0.000152	0.000951	CcSEcCtD
Amlodipine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000152	0.00126	CbGpPWpGaD
Amlodipine—Dermatitis—Doxorubicin—bone cancer	0.000152	0.00095	CcSEcCtD
Amlodipine—SMPD1—Metabolism—DHFR—bone cancer	0.000151	0.00126	CbGpPWpGaD
Amlodipine—Headache—Doxorubicin—bone cancer	0.000151	0.000944	CcSEcCtD
Amlodipine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.00015	0.00125	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—MET—bone cancer	0.000149	0.00124	CbGpPWpGaD
Amlodipine—CACNB2—Neuronal System—BRAF—bone cancer	0.000149	0.00124	CbGpPWpGaD
Amlodipine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000148	0.00124	CbGpPWpGaD
Amlodipine—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000147	0.00123	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—MMP2—bone cancer	0.000145	0.00121	CbGpPWpGaD
Amlodipine—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000145	0.00121	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000145	0.00121	CbGpPWpGaD
Amlodipine—Nausea—Doxorubicin—bone cancer	0.000143	0.000895	CcSEcCtD
Amlodipine—CACNA1D—Axon guidance—MET—bone cancer	0.000141	0.00118	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—GNA11—bone cancer	0.000141	0.00118	CbGpPWpGaD
Amlodipine—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000139	0.00116	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000137	0.00114	CbGpPWpGaD
Amlodipine—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000137	0.00114	CbGpPWpGaD
Amlodipine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.00013	0.00108	CbGpPWpGaD
Amlodipine—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000129	0.00107	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—CYP3A4—bone cancer	0.000128	0.00107	CbGpPWpGaD
Amlodipine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000127	0.00106	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000127	0.00106	CbGpPWpGaD
Amlodipine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000127	0.00106	CbGpPWpGaD
Amlodipine—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000126	0.00105	CbGpPWpGaD
Amlodipine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000126	0.00105	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000125	0.00104	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000125	0.00104	CbGpPWpGaD
Amlodipine—CACNB2—Neuronal System—MDM2—bone cancer	0.000125	0.00104	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—MMP2—bone cancer	0.000124	0.00104	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MET—bone cancer	0.000124	0.00103	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—CDK4—bone cancer	0.000124	0.00103	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—MET—bone cancer	0.000124	0.00103	CbGpPWpGaD
Amlodipine—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00103	CbGpPWpGaD
Amlodipine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000123	0.00103	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000123	0.00103	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000122	0.00102	CbGpPWpGaD
Amlodipine—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000119	0.00099	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—MMP2—bone cancer	0.000118	0.000982	CbGpPWpGaD
Amlodipine—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000117	0.000977	CbGpPWpGaD
Amlodipine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000117	0.000974	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000113	0.000939	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000112	0.000934	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000112	0.000931	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—GSTP1—bone cancer	0.000109	0.000911	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—MMP9—bone cancer	0.000109	0.000909	CbGpPWpGaD
Amlodipine—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000109	0.000908	CbGpPWpGaD
Amlodipine—ABCB1—bone marrow—bone cancer	0.000108	0.00462	CbGeAlD
Amlodipine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000107	0.000895	CbGpPWpGaD
Amlodipine—ABCB1—spinal cord—bone cancer	0.000107	0.0046	CbGeAlD
Amlodipine—CACNB2—Developmental Biology—CDK4—bone cancer	0.000106	0.000887	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MET—bone cancer	0.000106	0.000887	CbGpPWpGaD
Amlodipine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000105	0.000879	CbGpPWpGaD
Amlodipine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000105	0.000871	CbGpPWpGaD
Amlodipine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000104	0.000864	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MMP2—bone cancer	0.000104	0.000863	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—MMP2—bone cancer	0.000104	0.000863	CbGpPWpGaD
Amlodipine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000103	0.000859	CbGpPWpGaD
Amlodipine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.000852	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000102	0.00085	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000102	0.000847	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—NT5C3A—bone cancer	0.000101	0.000842	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MET—bone cancer	0.000101	0.00084	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—CDK4—bone cancer	0.000101	0.00084	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000101	0.000839	CbGpPWpGaD
Amlodipine—CA1—Metabolism—ENO2—bone cancer	0.000101	0.000837	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.54e-05	0.000795	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—MMP9—bone cancer	9.35e-05	0.000779	CbGpPWpGaD
Amlodipine—CA1—Metabolism—DHFR—bone cancer	9.32e-05	0.000777	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—NT5C3A—bone cancer	9.26e-05	0.000772	CbGpPWpGaD
Amlodipine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	9.03e-05	0.000752	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NDUFA12—bone cancer	9.02e-05	0.000751	CbGpPWpGaD
Amlodipine—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.94e-05	0.000745	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MMP2—bone cancer	8.88e-05	0.00074	CbGpPWpGaD
Amlodipine—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.87e-05	0.000739	CbGpPWpGaD
Amlodipine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.86e-05	0.000738	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MET—bone cancer	8.86e-05	0.000738	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—CDK4—bone cancer	8.86e-05	0.000738	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—MMP9—bone cancer	8.86e-05	0.000738	CbGpPWpGaD
Amlodipine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.82e-05	0.000735	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NDUFA12—bone cancer	8.82e-05	0.000734	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—EGFR—bone cancer	8.81e-05	0.000734	CbGpPWpGaD
Amlodipine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.75e-05	0.000729	CbGpPWpGaD
Amlodipine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.74e-05	0.000728	CbGpPWpGaD
Amlodipine—CA1—Metabolism—GNA11—bone cancer	8.72e-05	0.000726	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—ENO2—bone cancer	8.69e-05	0.000724	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.53e-05	0.000711	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.51e-05	0.000709	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MMP2—bone cancer	8.41e-05	0.000701	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NDUFA12—bone cancer	8.33e-05	0.000694	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—ENO2—bone cancer	8.23e-05	0.000685	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—DHFR—bone cancer	8.06e-05	0.000671	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.99e-05	0.000666	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.99e-05	0.000666	CbGpPWpGaD
Amlodipine—CA1—Metabolism—CYP3A4—bone cancer	7.9e-05	0.000658	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MMP9—bone cancer	7.78e-05	0.000649	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—MMP9—bone cancer	7.78e-05	0.000648	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NDUFA12—bone cancer	7.64e-05	0.000636	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—DHFR—bone cancer	7.63e-05	0.000636	CbGpPWpGaD
Amlodipine—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.58e-05	0.000631	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—EGFR—bone cancer	7.56e-05	0.00063	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—GNA11—bone cancer	7.53e-05	0.000628	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NT5C3A—bone cancer	7.47e-05	0.000623	CbGpPWpGaD
Amlodipine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.47e-05	0.000623	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MMP2—bone cancer	7.39e-05	0.000616	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.34e-05	0.000612	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NT5C3A—bone cancer	7.3e-05	0.000609	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—ENO2—bone cancer	7.23e-05	0.000602	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—EGFR—bone cancer	7.16e-05	0.000596	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—GNA11—bone cancer	7.13e-05	0.000594	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NT5C3A—bone cancer	6.9e-05	0.000575	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—CYP3A4—bone cancer	6.83e-05	0.000569	CbGpPWpGaD
Amlodipine—CA1—Metabolism—GSTP1—bone cancer	6.76e-05	0.000563	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—DHFR—bone cancer	6.71e-05	0.000559	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MMP9—bone cancer	6.67e-05	0.000556	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NDUFA12—bone cancer	6.65e-05	0.000554	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—CYP3A4—bone cancer	6.47e-05	0.000539	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.33e-05	0.000527	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NT5C3A—bone cancer	6.33e-05	0.000527	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MMP9—bone cancer	6.32e-05	0.000527	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—EGFR—bone cancer	6.29e-05	0.000524	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—EGFR—bone cancer	6.29e-05	0.000524	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NDUFA12—bone cancer	6.27e-05	0.000522	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—GNA11—bone cancer	6.27e-05	0.000522	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NDUFA12—bone cancer	6.21e-05	0.000518	CbGpPWpGaD
Amlodipine—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.85e-05	0.000487	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—GSTP1—bone cancer	5.84e-05	0.000487	CbGpPWpGaD
Amlodipine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.77e-05	0.000481	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—CYP3A4—bone cancer	5.68e-05	0.000473	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—PTGS2—bone cancer	5.67e-05	0.000472	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MMP9—bone cancer	5.55e-05	0.000463	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—GSTP1—bone cancer	5.53e-05	0.000461	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NT5C3A—bone cancer	5.51e-05	0.000459	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—EGFR—bone cancer	5.39e-05	0.000449	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NDUFA12—bone cancer	5.31e-05	0.000442	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NT5C3A—bone cancer	5.19e-05	0.000433	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NT5C3A—bone cancer	5.15e-05	0.000429	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—EGFR—bone cancer	5.11e-05	0.000425	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—GSTP1—bone cancer	4.86e-05	0.000405	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.69e-05	0.000391	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.52e-05	0.000377	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—EGFR—bone cancer	4.49e-05	0.000374	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—ENO2—bone cancer	4.43e-05	0.000369	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NT5C3A—bone cancer	4.4e-05	0.000367	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—DHFR—bone cancer	4.11e-05	0.000342	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.1e-05	0.000341	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.08e-05	0.00034	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—ENO2—bone cancer	4.06e-05	0.000338	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—GNA11—bone cancer	3.84e-05	0.00032	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—DHFR—bone cancer	3.76e-05	0.000314	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—GNA11—bone cancer	3.52e-05	0.000293	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PTGS2—bone cancer	3.5e-05	0.000292	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CYP3A4—bone cancer	3.48e-05	0.00029	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.4e-05	0.000283	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ENO2—bone cancer	3.27e-05	0.000273	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.21e-05	0.000267	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ENO2—bone cancer	3.2e-05	0.000267	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CYP3A4—bone cancer	3.19e-05	0.000266	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—DHFR—bone cancer	3.04e-05	0.000253	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PTGS2—bone cancer	3.03e-05	0.000252	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ENO2—bone cancer	3.02e-05	0.000252	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—GSTP1—bone cancer	2.98e-05	0.000248	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—DHFR—bone cancer	2.97e-05	0.000247	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PTGS2—bone cancer	2.87e-05	0.000239	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GNA11—bone cancer	2.84e-05	0.000236	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—DHFR—bone cancer	2.8e-05	0.000234	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GNA11—bone cancer	2.77e-05	0.000231	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ENO2—bone cancer	2.77e-05	0.000231	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—GSTP1—bone cancer	2.73e-05	0.000227	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.69e-05	0.000224	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GNA11—bone cancer	2.62e-05	0.000218	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CYP3A4—bone cancer	2.57e-05	0.000214	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—DHFR—bone cancer	2.57e-05	0.000214	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PTGS2—bone cancer	2.52e-05	0.00021	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CYP3A4—bone cancer	2.52e-05	0.00021	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ENO2—bone cancer	2.41e-05	0.000201	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GNA11—bone cancer	2.4e-05	0.0002	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CYP3A4—bone cancer	2.38e-05	0.000198	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.36e-05	0.000197	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ENO2—bone cancer	2.28e-05	0.00019	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ENO2—bone cancer	2.26e-05	0.000188	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—DHFR—bone cancer	2.24e-05	0.000187	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GSTP1—bone cancer	2.2e-05	0.000183	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.18e-05	0.000182	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.17e-05	0.000181	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GSTP1—bone cancer	2.15e-05	0.000179	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—DHFR—bone cancer	2.11e-05	0.000176	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GNA11—bone cancer	2.09e-05	0.000174	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—DHFR—bone cancer	2.09e-05	0.000174	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GSTP1—bone cancer	2.03e-05	0.000169	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GNA11—bone cancer	1.97e-05	0.000164	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GNA11—bone cancer	1.96e-05	0.000163	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ENO2—bone cancer	1.93e-05	0.000161	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CYP3A4—bone cancer	1.9e-05	0.000158	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GSTP1—bone cancer	1.86e-05	0.000155	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.79e-05	0.000149	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—DHFR—bone cancer	1.79e-05	0.000149	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.77e-05	0.000148	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.76e-05	0.000147	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GNA11—bone cancer	1.67e-05	0.000139	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTP1—bone cancer	1.62e-05	0.000135	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PTGS2—bone cancer	1.54e-05	0.000128	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTP1—bone cancer	1.53e-05	0.000127	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTP1—bone cancer	1.52e-05	0.000126	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.52e-05	0.000126	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.51e-05	0.000126	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ENO2—bone cancer	1.49e-05	0.000124	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PTGS2—bone cancer	1.41e-05	0.000118	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—DHFR—bone cancer	1.38e-05	0.000115	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTP1—bone cancer	1.3e-05	0.000108	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GNA11—bone cancer	1.29e-05	0.000107	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTGS2—bone cancer	1.14e-05	9.5e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTGS2—bone cancer	1.11e-05	9.28e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTGS2—bone cancer	1.05e-05	8.77e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTP1—bone cancer	1e-05	8.33e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTGS2—bone cancer	9.65e-06	8.04e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTGS2—bone cancer	8.41e-06	7.01e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTGS2—bone cancer	7.92e-06	6.6e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTGS2—bone cancer	7.86e-06	6.55e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTGS2—bone cancer	6.71e-06	5.59e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTGS2—bone cancer	5.18e-06	4.32e-05	CbGpPWpGaD
